Literature DB >> 18094536

Comparison of epitope structures of H3HAs through protein modeling of influenza A virus hemagglutinin: mechanism for selection of antigenic variants in the presence of a monoclonal antibody.

Setsuko Nakajima1, Katsuhisa Nakajima, Eri Nobusawa, Jin Zhao, Shigenori Tanaka, Kaori Fukuzawa.   

Abstract

Starting with nine plaques of influenza A/Kamata/14/91(H3N2) virus, we selected mutants in the presence of monoclonal antibody 203 (mAb203). In total, amino acid substitutions were found at nine positions (77, 80, 131, 135, 141, 142, 143, 144 and 146), which localized in the antigenic site A of the hemagglutinin (HA). The escape mutants differed in the extent to which they had lost binding to mAb203. HA protein with substitutions of some amino acid residues created by site-directed mutagenesis in the escape mutants retained the ability to bind to mAb203. Changes in the amino acid character affecting charge or hydrophobicity accounted for the binding capacity to the antibody of the HA with most of the substitutions in the escape mutants and binding-positive mutants. However, the effect of some amino acid substitutions remained unexplained. A three-dimensional model of the 1991 HA was constructed and used to analyze substituted amino acids in these mutants for the accessible surface hydrophobic and hydrophilic characters. One amino acid substitution in an escape mutant and another amino acid substitution in a binding-positive mutant seemed to be explained by the changes noted on this model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094536     DOI: 10.1111/j.1348-0421.2007.tb04013.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  8 in total

1.  Epitope mapping of the hemagglutinin molecule of A/(H1N1)pdm09 influenza virus by using monoclonal antibody escape mutants.

Authors:  Yoko Matsuzaki; Kanetsu Sugawara; Mina Nakauchi; Yoshimasa Takahashi; Taishi Onodera; Yasuko Tsunetsugu-Yokota; Takayuki Matsumura; Manabu Ato; Kazuo Kobayashi; Yoshitaka Shimotai; Katsumi Mizuta; Seiji Hongo; Masato Tashiro; Eri Nobusawa
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

2.  Selective pressure to increase charge in immunodominant epitopes of the H3 hemagglutinin influenza protein.

Authors:  Keyao Pan; Jinxue Long; Haoxin Sun; Gregory J Tobin; Peter L Nara; Michael W Deem
Journal:  J Mol Evol       Date:  2010-11-18       Impact factor: 2.395

3.  New p35 (H3L) Epitope Involved in Vaccinia Virus Neutralization and Its Deimmunization.

Authors:  Yana Khlusevich; Andrey Matveev; Lyudmila Emelyanova; Elena Goncharova; Natalia Golosova; Ivan Pereverzev; Nina Tikunova
Journal:  Viruses       Date:  2022-06-05       Impact factor: 5.818

4.  Temporal distribution and genetic variants in influenza A(H1N1)pdm09 virus circulating in Mexico, seasons 2012 and 2013.

Authors:  Jose Reyes Canche-Pech; Laura Conde-Ferraez; Marylin Puerto-Solis; Refugio Gonzalez-Losa; Pilar Granja-Pérez; Salha Villanueva-Jorge; Maria Chan-Gasca; Jesus Gómez-Carballo; Luisa López-Ochoa; Bertha Jiménez-Delgadillo; Iram Rodríguez-Sánchez; Jorge Ramírez-Prado; Guadalupe Ayora-Talavera
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

5.  Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of H7N9 Influenza Viruses.

Authors:  Zhihao Sun; Baolan Shi; Feifei Meng; Ruonan Ma; Qingyun Hu; Tao Qin; Sujuan Chen; Daxin Peng; Xiufan Liu
Journal:  Front Microbiol       Date:  2018-08-31       Impact factor: 5.640

Review 6.  Design and Engineering of Deimmunized Vaccinia Viral Vectors.

Authors:  Kevin Song; Mariya Viskovska
Journal:  Biomedicines       Date:  2020-11-11

7.  Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.

Authors:  Jorge M Dinis; Kelsey R Florek; Omolayo O Fatola; Louise H Moncla; James P Mutschler; Olivia K Charlier; Jennifer K Meece; Edward A Belongia; Thomas C Friedrich
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

8.  Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors.

Authors:  Ritsuko Kubota-Koketsu; Hiroyuki Mizuta; Masatoshi Oshita; Shoji Ideno; Mikihiro Yunoki; Motoki Kuhara; Naomasa Yamamoto; Yoshinobu Okuno; Kazuyoshi Ikuta
Journal:  Biochem Biophys Res Commun       Date:  2009-07-04       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.